Loading clinical trials...
Loading clinical trials...
To obtain a genotypic analysis of patients with chronic exudative age-related macular degeneration noted to have subretinal or intraretinal edema despite continuous monthly Anti-VEGF therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
West Coast Retina Medical Group, Inc.
Collaborators
NCT05210803 · Neovascular Age-Related Macular Degeneration (nAMD), Gene Therapy, and more
NCT06704009 · Wet Age Related Macular Degeneration, Wet AMD
NCT02634970 · Wet Age-related Macular Degeneration (Wet AMD)
West Coast Retina Medical Group, Inc.
San Francisco, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions